Author:
Dill Patricia E.,De Bernardis Gaston,Weber Peter,Lösch Uli
Subject
Neurology (clinical),Developmental Neuroscience,Neurology,Pediatrics, Perinatology and Child Health
Reference29 articles.
1. Non-penetrance in tuberous sclerosis;Osborne;Lancet,2000
2. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth;Huang;Biochem J,2008
3. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial;Franz;Lancet,2012
4. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial;Bissler;Lancet,2013
5. FDA Drug Approval and Databases: Everolimus for Tuberous Sclerosis Complex (TSC). Available at: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm317490.htm. Accessed September 24, 2013.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献